Announcement of Resolutions of the 2025 Annual Shareholders Meeting
Securities code: 603716 Securities abbreviation: Sailis Medical Announcement number: 2026-042 Sailis Medical Technology Group Co., Ltd.
The company and all members of the board of directors guarantee that there are no false records, misleading statements or major omissions in the announcement content, and assume legal responsibility for the authenticity, accuracy and completeness of its content.
Important content reminder:
Is there any veto resolution at this meeting: None
1. Meeting convening and attendance
(1) Time of the shareholders’ meeting: May 19, 2026
(2) The location of the shareholders’ meeting: Meeting A, Building A, the company (No. 1310 Jinshan Avenue, Dongxihu District, Wuhan City)
meeting room
(3) Common shareholders attending the meeting and preference shareholders whose voting rights have been restored and their holdings:
Number of shareholders and proxies attending the meeting 728
Total number of voting shares held by shareholders attending the meeting (shares) 33,725,539
The number of voting shares held by shareholders attending the meeting accounts for the company’s voting shares.
Proportion of total number of copies (%) 15.2045
(4) Whether the voting method complies with the provisions of the "Company Law" and the "Articles of Association", the status of the meeting, etc.
This shareholders' meeting was convened by the board of directors of Thalys Medical Technology Group Co., Ltd. and chaired by Mr. Wen Wei, chairman of the company. The convening, holding and voting methods of this meeting complied with the relevant provisions of relevant laws, administrative regulations, departmental rules and the Articles of Association.
(5) Attendance of company directors and board secretary
The company has 9 current directors and 9 people are present;
Ms. Fan Li, Secretary of the Board of Directors, attended this meeting; other senior executives attended this meeting as non-voting delegates.
2. Proposal review status
(1) Non-cumulative voting proposals
- Proposal Name: Proposal on the 2025 Board of Directors Work Report
Review result: Passed
Voting status:
Agree Disagree Abstaining shareholder type Ratio
Number of votes Proportion (%) Number of votes Proportion (%) (%)
A shares 33,301,960 98.7440 360,265 1.0682 63,314 0.1878
- Proposal Name: Proposal on the 2025 Profit Distribution Plan
Review result: Passed
Voting status:
Agree Objection Abstaining shareholder type Proportion Proportion of votes Proportion (%) Number of votes Number of votes
(%) (%)
A shares 33,371,386 98.9498 260,715 0.7730 93,438 0.2772
- Proposal Name: Proposal on Re-appointment of Accounting Firm
Review result: Passed
Voting status:
Agree Disagree Abstain
Type of shareholder Proportion Proportional number of votes Proportion (%) Number of votes Number of votes
(%) (%)
A shares 33,408,443 99.0597 240,282 0.7124 76,814 0.2279
- Proposal name: Proposal review results on confirming the company’s directors’ 2025 remuneration and 2026 remuneration plan: passed
Voting status:
Agree Disagree Abstain
Type of shareholder Proportional number of votes Proportion (%) Number of votes Proportion (%) Number of votes
(%)
A shares 1,936,789 79.1433 415,064 16.9608 95,338 3.8959
- Proposal Name: Proposal on Amending the "Remuneration Management Measures for Directors and Senior Management Personnel"
Review result: Passed
Voting status:
Agree Disagree Abstain
Type of shareholder Proportion Proportional number of votes Proportion (%) Number of votes Number of votes
(%) (%) A shares 33,211,737 98.4765 433,764 1.2861 80,038 0.2374
- Proposal Name: Proposal on Shareholder Return Planning for the Next Three Years (2026-2028)
Review result: Passed
Voting status:
Agree Disagree Abstain
Type of shareholder Proportion Proportional number of votes Proportion (%) Number of votes Number of votes
(%) (%) A shares 33,280,160 98.6794 362,865 1.0759 82,514 0.2447
- Proposal Name: Proposal on the Company’s Uncovered Losses Reaching One-third of the Total Paid-in Share Capital
Review result: Passed
Voting status:
Agree Disagree Abstain
Type of shareholder Proportion Proportional number of votes Proportion (%) Number of votes Number of votes
(%) (%) A shares 33,216,703 98.4912 412,939 1.2244 95,897 0.2844
- Proposal Name: Proposal on Changing Registered Capital and Amending the Articles of Association
Review result: Passed
Voting status:
Agree Disagree Abstain
Shareholder type
Number of votes Proportion (%) Number of votes Proportion Number of votes Proportion
(%) (%) A shares 33,284,136 98.6911 378,582 1.1225 62,821 0.1864
- Proposal Name: Proposal on terminating some fundraising projects and permanently replenishing working capital with remaining raised funds
Review result: Passed
Voting status:
Agree Disagree Abstain
Type of shareholder Proportion Proportional number of votes Proportion (%) Number of votes Number of votes
(%) (%) A shares 33,408,227 99.0591 255,298 0.7569 62,014 0.1840
(2) When major matters are involved, the voting status of shareholders below 5%
- Non-cumulative voting proposals
Agree Disagree Abstain
motion
Motion name Proportion number Number of votes Proportion (%) Number of votes Proportion (%) Number of votes
(%)2 About 2025
2,092 260,7
Profit distribution plan 85.5275 10.6540 93,438 3.8185
,938 15
motion
3 Regarding the re-appointment of accountants
2,129 240,2
Law firm’s proposal 87.0419 9.8190 76,814 3.1391
,995 82
case
4 About confirming the company
Director 2025
1,936 415,0
Salary and 2026 79.1425 16.9615 95,338 3.8960
,689 64
compensation plan
motion
(3) Explanation of relevant circumstances regarding voting on motions
Proposal 8 is a special resolution proposal that has been reviewed and approved by more than two-thirds of the total voting rights held by shareholders with voting rights (including shareholders’ agents) who participated in on-site and online voting;
For motions 2, 3, and 4, the votes of small and medium-sized investors have been counted separately.
3. Lawyer’s testimony
(1) Law firm witnessing this shareholder meeting: Guoco Law Firm (Shanghai)
Lawyers: Li Chen, Wang Yi
(2) Lawyer’s concluding comments:
Our lawyers believe that the company’s convening and convening procedures of this shareholders’ meeting comply with the provisions of relevant laws, regulations, normative documents and the Articles of Association. The qualifications of the personnel attending this shareholders’ meeting and the qualifications of the convener are legal and valid. The voting procedures and voting results of this shareholders’ meeting are legal and valid.
Announcement is hereby made.
The Board of Directors of Thalys Medical Technology Group Co., Ltd.
May 20, 2026